Facebook Linkedin Twitter
Inside Precision Medicine Veracyte Adds AI-Driven MRD Testing Capabilities with C2i Genomics Acquisition

Veracyte

Blood draw for liquid biopsy.
News & Features

Veracyte Adds AI-Driven MRD Testing Capabilities with C2i Genomics Acquisition

Jonathan D. Grinstein, PhD
0
X-ray of lung showing chest cancer
News & Features

Nasal Swab Test Separates High- from Low-Risk Lung Cancer Polyps

0
Prostate cancer cells
Molecular Dx

Veracyte’s Genomic Prostate Test Validated for High-Risk Prostate Cancer Prognosis

0
Bladder Cancer
Molecular Dx

Veractye to Buy Decipher Biosciences

0
woman in lab
News & Features

Top Women in Precision Medicine

0
Human heart
Molecular Dx

CareDx, Veracyte Enter Exclusive Partnership for Transplant Rejection Testing

0
Illustration of the lungs to represent lung disease, which can be diagnosed using specialist ultrasound
Molecular Dx

Veracyte Gets Exclusive License to IPF Gene Signature from Yale

0
Meeting handshake
Molecular Dx

Veracyte Nabs Exclusive Global License for Diagnostic Use of Nanostring’s nCounter Technology

0
While thyroid cancer is very treatable with surgery and other therapies
News & Features

New Studies Underscore Value of Biomarker Testing in Thyroid Cancer

0
While thyroid cancer is very treatable with surgery and other therapies
Molecular Dx

New Data Validates Veracyte’s Test for Thyroid Cancer Treatment Guidance

0
12Page 1 of 2

Related Content

Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine